Introduction
Benign prostatic hyperplasia (BPH), or enlarged prostate, affects over 50% of men aged 60 and older, causing urinary symptoms like frequent urination, weak stream, and incomplete bladder emptying. While medications such as alpha-blockers and 5-alpha reductase inhibitors manage mild cases, surgery offers a potential cure for moderate to severe symptoms unresponsive to drugs. This article explores proven surgical options, highlighting procedures, benefits, risks, and recovery, empowering patients to discuss informed choices with urologists.
Understanding Enlarged Prostate
BPH involves non-cancerous prostate gland growth around the urethra, obstructing urine flow. The prostate enlarges due to hormonal changes, particularly dihydrotestosterone accumulation. Symptoms impact quality of life, with nocturia affecting sleep and risks of complications like urinary retention, bladder stones, or kidney damage. Diagnosed via digital rectal exam, PSA tests, ultrasound, and uroflowmetry, surgery is recommended when prostates exceed 30-40 grams or symptoms score high on the International Prostate Symptom Score (IPSS).
Transurethral Resection of the Prostate (TURP)
TURP, the gold standard since the 1920s, remains the most common BPH surgery, performed on over 150,000 U.S. men annually. Under spinal or general anesthesia, a resectoscope through the urethra removes obstructing prostate tissue using electric current. It cures symptoms in 80-90% of patients, improving urine flow by 16 ml/second on average. Hospital stays last 1-3 days, with catheter use for 1-2 days. Risks include bleeding (2-5%), retrograde ejaculation (65-70%), and incontinence (1-2%). Long-term reoperation rates are 1-2% per year.
Laser Therapies
Laser surgeries provide minimally invasive alternatives to TURP, ideal for larger prostates (up to 200 grams). Holmium laser enucleation of the prostate (HoLEP) uses a laser to enucleate and morcellate tissue, offering durable results comparable to open surgery with less blood loss. Photoselective vaporization of the prostate (PVP or GreenLight) vaporizes tissue precisely, allowing same-day discharge. Success rates exceed 85%, with fewer sexual side effects (retrograde ejaculation in 30-40%). Recovery takes 1-2 weeks, minimizing catheterization to under 24 hours.
Minimally Invasive Procedures
Emerging options like UroLift and Rezum target smaller prostates (<80 grams). UroLift implants compress encroaching lobes, preserving ejaculation in 90% of cases; outpatient procedure with 4-week recovery. Rezum uses water vapor injections to shrink tissue, effective for IPSS reductions of 50%, with low retreatment rates (4.4% at 5 years). These preserve prostate anatomy, avoiding resection risks, though less suitable for very large glands.
Open and Robotic Prostatectomy
For massive prostates (>100 grams), open simple prostatectomy or robotic-assisted laparoscopic prostatectomy removes the inner adenoma. Performed via abdominal incision or laparoscopically, they achieve over 95% symptom resolution but require 4-6 week recovery and higher bleeding risks (5-10%). Robotic approaches enhance precision, reducing hospital stays to 2-4 days.
Conclusion
Surgical options for enlarged prostate range from TURP’s proven efficacy to laser and minimally invasive innovations, tailored by prostate size, symptoms, and patient health. Success hinges on urologist expertise and patient selection, with most achieving lasting relief. Consult specialists for personalized risks versus benefits, as early intervention prevents complications and restores urinary health effectively.